Bridelia ferruginea produces antineuroinflammatory activity through inhibition of nuclear factor-kappa B and p38 MAPK signalling

Olumayokun A. Olajide, Mutalib A. Aderogba, Uchechukwu P. Okorji, Bernd L. Fiebich

Research output: Contribution to journalArticle

6 Citations (Scopus)


Bridelia ferruginea is commonly used in traditional African medicine (TAM) for treating various inflammatory conditions. Extracts from the plant have been shown to exhibit anti-inflammatory property in a number of in vivo models. In this study the influence of B. ferruginea (BFE) on the production of PGE nitrite, and proinflammatory cytokines from LPS-stimulated BV-2 microglia was investigated. The effects of BFE on cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) protein expressions were evaluated in LPS-activated rat primary microglia. The roles of NF-B and MAPK signalling in the actions of BFE were also investigated. BFE (25-200 g) inhibited the production of PGE nitrite, tumour necrosis factor-α (TNFα), and interleukin-6 (IL-6) as well as COX-2 and iNOS protein expressions in LPS-activated microglial cells. Further studies to elucidate the mechanism of anti-inflammatory action of BFE revealed interference with nuclear translocation of NF-Bp65 through mechanisms involving inhibition of IB degradation. BFE prevented phosphorylation of p38, but not p42/44 or JNK MAPK. It is suggested that Bridelia ferruginea produces anti-inflammatory action through mechanisms involving p38 MAPK and NF-B signalling.

Original languageEnglish
Article number546873
Number of pages8
JournalEvidence-based Complementary and Alternative Medicine
Publication statusPublished - 1 Dec 2012


Cite this